EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Therapeutic Cocktail Approach for Treatment of Hyperhomocysteinemia in Alzheimer’s Disease

Michael Leon, Darrell Sawmiller, R Douglas Shytle, Jun Tan

Cell Medicine · 2018

DOI: 10.1177/2155179017722280 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cell Medicine, 2018. Verfasst von Michael Leon und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry and Behavioral Neurosciences, Rashid Laboratory for Developmental Neurobiology, Silver Child Development Center, Morsani Col…. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the United States, Alzheimer's disease (AD) is the most common cause of dementia, accompanied by substantial economic and emotional costs. During 2015, more than 15 million family members who provided care to AD patients had an estimated total cost of 221 billion dollars. Recent studies have shown that elevated total plasma levels of homocysteine (tHcy), a condition known as hyperhomocysteinemia (HHcy), is a risk factor for AD. HHcy is associated with cognitive decline, brain atrophy, and dementia; enhances the vulnerability of neurons to oxidative injury; and damages the blood–brain barrier. Many therapeutic supplements containing vitamin B12 and folate have been studied to help decrease tHcy to a certain degree. However, a therapeutic cocktail approach with 5-methyltetrahydrofolate, methyl B12, betaine, and N-acetylcysteine (NAC) have not been studied. This novel approach may help target multiple pathways simultaneously to decrease tHcy and its toxicity substantially.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer's diseaseN-acetylcysteine (NAC)betainefolateglutathione (GSH)hyperhomocysteinemia (HHcy)reactive oxygen species (ROS)total homocysteine (tHcy)vitamin B12

Autor:innen und Institutionen

  • Department of Psychiatry and Behavioral Neurosciences, Rashid Laboratory for Developmental Neurobiology, Silver Child Development Center, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.
  • Department of Neurosurgery and Brain Repair, Center for Excellence in Aging and Brain Repair, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.

Zitieren

APA

Leon, M., Sawmiller, D., Shytle, R. D., & Tan, J. (2018). Therapeutic Cocktail Approach for Treatment of Hyperhomocysteinemia in Alzheimer’s Disease. Cell Medicine. https://doi.org/10.1177/2155179017722280

Vancouver

Leon M, Sawmiller D, Shytle RD, Tan J. Therapeutic Cocktail Approach for Treatment of Hyperhomocysteinemia in Alzheimer’s Disease. Cell Medicine. 2018. doi:10.1177/2155179017722280

BibTeX
@article{Leon2018,
  author = {Leon, Michael and Sawmiller, Darrell and Shytle, R Douglas and Tan, Jun},
  title = {Therapeutic Cocktail Approach for Treatment of Hyperhomocysteinemia in Alzheimer’s Disease},
  journal = {Cell Medicine},
  year = {2018},
  doi = {10.1177/2155179017722280}
}
Kostenlos starten →